Cutaneous leishmaniasis

被引:200
作者
Bailey, Mark S.
Lockwood, Diana N. J. [1 ]
机构
[1] Univ London London Sch Hyg & Trop Med, Clin Res Unit, London WC1E 7HT, England
[2] Army Med Directorate, Camberley GU15 4NP, England
[3] Univ Liverpool, Liverpool Sch Trop Med, Clin Res Grp, Liverpool L3 5QA, Merseyside, England
关键词
D O I
10.1016/j.clindermatol.2006.05.008
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Cutaneous leishmaniasis is a widespread tropical infection caused by numerous different species of Leishmania protozoa that are transmitted by sandflies. Its clinical presentations are extremely diverse and dependent on a variety of parasite and host factors that are poorly understood. Diagnosis should aim to identify the exact species involved, but this requires laboratory investigations that are not widely available. No single ideal treatment has been identified, and those available are limited by variable success rates and toxicity. Clinical guidelines are needed to make better use of the investigations and treatments that do exist. Prevention is currently limited to bite prevention measures. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:203 / 211
页数:9
相关论文
共 80 条
[1]   Lesson of the week; Mucocutaneous leishmaniasis: an imported infection among travellers to central and South America [J].
Ahluwalia, S ;
Lawn, SD ;
Kanagalingam, J ;
Grant, H ;
Lockwood, DNJ .
BMJ-BRITISH MEDICAL JOURNAL, 2004, 329 (7470) :842-844
[2]  
Al-Jaser MH, 2005, SAUDI MED J, V26, P1220
[3]   Dissemination in cutaneous leishmaniasis due to Leishmania major in different ethnic groups in Saudi Arabia [J].
Al-Qurashi, AR ;
Ghandour, AM ;
Osman, M ;
Al-Juma, M .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2000, 39 (11) :832-836
[4]   A sensitive new microculture method for diagnosis of cutaneous leishmaniasis [J].
Allahverdiyev, AM ;
Uzun, S ;
Bagirova, M ;
Durdu, M ;
Memisoglu, HR .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2004, 70 (03) :294-297
[5]   Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major [J].
Alrajhi, AA ;
Ibrahim, EA ;
De Vol, EB ;
Khairat, M ;
Faris, RM ;
Maguire, JH .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (12) :891-895
[6]   Comparison of meglumine antimoniate and pentamidine for Peruvian cutaneous leishmaniasis [J].
Andersen, EM ;
Cruz-Saldarriaga, M ;
Llanos-Cuentas, A ;
Luz-Cjuno, M ;
Echevarria, J ;
Miranda-Verastegui, C ;
Colina, O ;
Berman, JD .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2005, 72 (02) :133-137
[7]   Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala [J].
Arana, BA ;
Mendoza, CE ;
Rizzo, NR ;
Kroeger, A .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2001, 65 (05) :466-470
[8]   Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis [J].
Armijos, RX ;
Weigel, MM ;
Calvopiña, M ;
Mancheno, M ;
Rodriguez, R .
ACTA TROPICA, 2004, 91 (02) :153-160
[9]   Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: Recent US military experience [J].
Aronson, NE ;
Wortmann, GW ;
Johnson, SC ;
Jackson, JE ;
Gasser, RA ;
Magill, AJ ;
Endy, TP ;
Coyne, PE ;
Grogl, M ;
Benson, PM ;
Beard, JS ;
Tally, JD ;
Gambel, JM ;
Kreutzer, RD ;
Oster, CN .
CLINICAL INFECTIOUS DISEASES, 1998, 27 (06) :1457-1464
[10]   Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime®) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime®) alone for the treatment of cutaneous leishmaniasis [J].
Asilian, A ;
Sadeghinia, A ;
Faghihi, G ;
Momeni, A .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2004, 43 (04) :281-283